← Back to Clinical Trials
Recruiting NCT07579143

NCT07579143 Mental Health Clinician / Chaplain Collaboration

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07579143
Status Recruiting
Phase
Sponsor Central Arkansas Veterans Healthcare System
Condition Moral Injury
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-04-14
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
facilitate forgiveness and community connection to address symptoms of moral injury

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-04-14 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if the intervention can be delivered by VA chaplains and if it is acceptable for veterans who have symptoms of moral injury (guilt, shame, isolation) and are receiving VA mental health treatment. The main questions it aims to answer are: Can the study team enroll veterans for this intervention and complete data collection? Will veterans complete the intervention? There is no comparison group. Participants will will complete a baseline and 6-month interview and participate in up to 12 intervention sessions with a VA chaplain. The intervention will focus on facilitating forgiveness and community connection.

Eligibility Criteria

Inclusion Criteria: * age 18 to 80 years * plan to follow-up with a VA mental health clinician for PTSD or SUD treatment within the next three months (therefore allowing for collaboration) * positive screen using the 6-item Moral Injury Distress Scale (MIDS) screener. A positive MIDS screen will be defined as being bothered at least moderately by exposure to at least one potentially morally injurious event (witnessing, omission, commission). Exclusion Criteria: * diagnosis of schizophrenia, bipolar disorder, borderline personality disorder, or severe neurocognitive disorder (e.g., dementia, severe TBI). Veterans with borderline personality disorder will be eligible for participation in this study following DBT completion. * Planning to start or current participation in a moral injury treatment group or evidence-based psychotherapy (e.g., Prolonged Exposure or Cognitive Processing Therapy).

Contact & Investigator

Central Contact

Jeff M Pyne, MD

✉ jeffrey.pyne@va.gov

📞 501-442-6019

Frequently Asked Questions

Who can join the NCT07579143 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Moral Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07579143 currently recruiting?

Yes, NCT07579143 is actively recruiting participants. Contact the research team at jeffrey.pyne@va.gov for enrollment information.

Where is the NCT07579143 trial being conducted?

This trial is being conducted at Little Rock, United States, Pittsburgh, United States.

Who is sponsoring the NCT07579143 clinical trial?

NCT07579143 is sponsored by Central Arkansas Veterans Healthcare System. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology